High purity Fluconazole in stock manufacturer CAS NO.86386-73-4

description:

fluconazole is a novel kind triazole drug of anti-fungal infection which was first successfully developed by the american pfizer with broad-spectrum anti-fungal effect. it belongs to a kind of systemic anti-fungal products and has high selectivity on the inhibitory effect of the fungal cytochrome p450-dependent enzyme. it is also a kind of potent and specific inhibitor for the fungi alcohol synthesis.

clinically it is mainly used for the treatment of vaginal candidiasis, thrush, atrophic oral candidiasis, fungal meningitis, pulmonary fungal infections, abdominal infections, urinary tract infections and skin fungi infection.

the main indication for fluconazole:

systemic candidiasis: including candidemia, disseminated candidiasis and other forms of invasive candida infections such as the peritoneum, endocardium, lungs and urinary tract infections. it can also be applied to patients of malignant tumors, special-care patients, patients who received radiotherapy, chemotherapy or immunosuppressive therapy as well as patients who are susceptible to other factors such as infection of candida. it can also be used for prevention of the occurrence of candida infection for bone marrow transplant patients upon receiving cytotoxic drugs treatment or radiation treatment.


mucosal candidiasis: including oropharyngeal, esophageal, non-invasive bronchial mucosal candidiasis, pulmonary candidiasis, candida urine disease, mucocutaneous and chronic atrophic oral candidiasis. it can be applied to patients of both normal immune function and with impaired immune function.

fluconazole can be used as substitute of itraconazole for the treatment of blastomycosis and histoplasmosis.

it can be used for the treatment of acute or recurrent vaginal candidiasis.

for leukemia patients or patients of other malignant tumor who is susceptible to fungal infection upon undergoing chemotherapy or radiotherapy can apply it as means of preventive treatment.
it can be used for the treatment coccidioidomycosis.

it can be used for treatment of fungal skin disease including fungal skin infections such as body ringworm, tinea pedis, tinea versicolor, tinea capitis, onychomycosis and nail ringworm.

medical usage:

this product belongs to fluorinated triazole antifungal drug with the antifungal spectrum being similar as ketoconazole but antifungal activity being higher than ketoconazole. its mechanism of action is through inhibition of essential component of the fungal cell membrane, the ergosterol biosynthesis enzyme, blocking the ergosterol synthesis and breaking the integrity of the fungal cell wall, further inhibiting their growth and reproduction. the product has potent antifungal activity against candida albicans, microsporum canis, cryptococcus neoformans, histoplasma capsulatum and epidermophyton.



coa: